Balentine LLC’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2018
Q1
Sell
-43
Closed -$13K 549
2017
Q4
$13K Buy
43
+29
+207% +$8.77K ﹤0.01% 443
2017
Q3
$5K Buy
+14
New +$5K ﹤0.01% 525